Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Oct 26, 8:35 AMDarioHealth announces contract expansion with regional grocery retailer to add Dario Women perimenopause and menopause program beginning January 2027
Index
-
Market Cap
33.81M
Enterprise Value
51.97M
Income
-41.86M
Sales
21.00M
Book/sh
7.50
Cash/sh
1.45
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
165
IPO
Apr 09, 2013
P/E
-
Forward P/E
-
PEG
-
P/S
1.61
P/B
0.46
P/C
2.37
P/FCF
-
EV/EBITDA
-
EV/Sales
2.47
Quick Ratio
1.92
Current Ratio
2.31
Debt/Eq
0.59
LT Debt/Eq
0.58
Option/Short
No / Yes
EPS (ttm)
-7.49
EPS next Y
-2.52
EPS next Q
-0.95
EPS this Y
60.70%
EPS next Y
36.63%
EPS next 5Y
45.15%
EPS past 3/5Y
41.57% 38.06%
Sales past 3/5Y
-6.84% 24.17%
EPS Y/Y TTM
62.36%
Sales Y/Y TTM
-22.65%
EPS Q/Q
78.49%
Sales Q/Q
-3.58%
Insider Own
25.07%
Insider Trans
0.59%
Inst Own
8.74%
Inst Trans
0.54%
ROA
-32.34%
ROE
-55.65%
ROIC
-38.12%
Gross Margin
58.15%
Oper. Margin
-151.60%
Profit Margin
-199.33%
SMA20
-31.69%
SMA50
-44.48%
SMA200
-56.19%
Trades
Shs Outstand
9.80M
Shs Float
7.34M
52W High
16.44 -79.01%
52W Low
3.01 14.62%
Volatility
23.15% 12.95%
ATR (14)
0.58
RSI (14)
26.17
Beta
1.12
Rel Volume
0.84
Avg Volume
34.05K
Volume
27,960
Perf Week
-15.44%
Perf Month
-48.58%
Perf Quarter
-51.41%
Perf Half Y
-53.38%
Perf YTD
-69.68%
Perf Year
-78.10%
Perf 3Y
-86.73%
Perf 5Y
-98.89%
Perf 10Y
-99.73%
Prev Close
3.40
Price
3.45
Change %
1.47%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Matheis DennisDirectorJul 23 '26Buy6.9314,430100,00043,026Jul 28 05:27 PM
DarioHealth Corp. is a digital health company which offers a user-centric and multi-chronic condition digital therapeutics platform that delivers personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company was founded by Oren Fuerst, Shoshana Friedman, David Weintraub, Dov Oppenheim, and Shilo Ben Zeev on August 11, 2011 and is headquartered in New York, NY.
CEO & DirectorMr. Erez Raphael
CFOMs. Chen Franco-Yehuda
ConsultantMr. Steven C. Nelson
Co-Founder & Production ChiefDov Oppenheim
Chief Operations OfficerLara Dodo